HDAC9 and colonic neoplasm: Additionally, to determine whether silibinin alters HDAC and DNMT activity in colon cancer progression, Kauntz et al. [206] conducted a study that revealed that silibinin does not modify the activity of HDACs, but is able to significantly inhibit DNMT activity in both SW480 and SW620 cells.